Medicare Enrolled
Dr. Fred Umeh, MD
Pulmonary Disease · Kissimmee, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Umeh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Umeh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Umeh
Dr. Fred Umeh is a pulmonary disease specialist in Kissimmee, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Umeh performed 2,900 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Umeh received a total of $299,782 from 59 pharmaceutical and/or device companies across 1153 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Umeh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in FL
$299,782 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 97024 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,900
Medicare services
Top 19% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
730 | $95 | $230 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
588 | $92 | $215 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
296 | $19 | $73 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
284 | $39 | $109 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
276 | $42 | $108 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
162 | $66 | $145 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
100 | $11 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $138 | $388 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
81 | $64 | $143 |
| New patient office visit, complex (60-74 min) | 72 | $173 | $414 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
64 | $26 | $75 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
53 | $104 | $290 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $133 | $288 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
41 | $171 | $568 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $122 | $334 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$299,782
Total received (2018-2024)
Avg $42,826/year across 7 years
Top 1% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,153
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$57,447
2023
$68,630
2022
$70,333
2021
$49,599
2020
$37,312
2019
$13,125
2018
$3,337
Payments by company (2024)
GlaxoSmithKline, LLC.
$31,017
AstraZeneca Pharmaceuticals LP
$23,594
GENZYME CORPORATION
$615
Insmed, Inc.
$229
Grifols USA, LLC
$213
Takeda Pharmaceuticals U.S.A., Inc.
$188
Boehringer Ingelheim Pharmaceuticals, Inc.
$182
JAZZ PHARMACEUTICALS INC.
$177
Amgen Inc.
$146
Pulmonx Corporation
$141
Actelion Pharmaceuticals US, Inc.
$127
Gilead Sciences, Inc.
$121
Avadel CNS Pharmaceuticals, LLC
$115
Axsome Therapeutics, Inc.
$114
Regeneron Healthcare Solutions, Inc.
$88
Philips North America LLC
$78
Baxter Healthcare
$73
Vifor Pharma, Inc.
$70
HARMONY BIOSCIENCES LLC
$47
United Therapeutics Corporation
$30
Merck Sharp & Dohme LLC
$27
Electromed, Inc.
$24
Genentech USA, Inc.
$18
Janssen Pharmaceuticals, Inc
$13
Top 3 companies account for 96.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$226,898
AstraZeneca Pharmaceuticals LP
$50,098
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,357
Allergan, Inc.
$3,188
ViiV Healthcare Company
$1,600
GENZYME CORPORATION
$1,488
Actelion Pharmaceuticals US, Inc.
$1,211
Grifols USA, LLC
$1,076
Philips Electronics North America Corporation
$870
United Therapeutics Corporation
$814
Regeneron Healthcare Solutions, Inc.
$762
JAZZ PHARMACEUTICALS INC.
$734
Insmed, Inc.
$712
Gilead Sciences, Inc.
$561
Genentech USA, Inc.
$466
Bayer HealthCare Pharmaceuticals Inc.
$440
Takeda Pharmaceuticals U.S.A., Inc.
$411
Mylan Specialty L.P.
$316
PORTOLA PHARMACEUTICALS, INC.
$300
Paratek Pharmaceuticals, Inc.
$293
Novartis Pharmaceuticals Corporation
$288
E.R. Squibb & Sons, L.L.C.
$273
Janssen Pharmaceuticals, Inc
$267
Harmony Biosciences LLC
$239
Vapotherm Inc
$202
HARMONY BIOSCIENCES LLC
$195
Amgen Inc.
$192
ZOLL Respicardia, Inc.
$170
Teva Pharmaceuticals USA, Inc.
$148
ABIOMED
$145
Bayer Healthcare Pharmaceuticals Inc.
$142
Pulmonx Corporation
$141
La Jolla Pharmaceutical Company
$129
Astute Medical, Inc.
$126
PFIZER INC.
$125
IDORSIA PHARMACEUTICALS US INC
$125
Merck Sharp & Dohme Corporation
$124
Jazz Pharmaceuticals Inc.
$120
SUN PHARMACEUTICAL INDUSTRIES INC.
$118
Avadel CNS Pharmaceuticals, LLC
$115
Axsome Therapeutics, Inc.
$114
Boston Scientific Corporation
$98
Philips North America LLC
$78
Baxter Healthcare
$73
Vifor Pharma, Inc.
$70
Electromed, Inc.
$68
Allergan Inc.
$58
Merck Sharp & Dohme LLC
$43
Circassia Pharmaceuticals Inc
$34
Ethicon Inc.
$32
Fisher & Paykel Healthcare Inc
$19
Sandoz Inc.
$19
Exeltis, USA Inc.
$17
Inogen, Inc.
$17
Eisai Inc.
$15
Shire North American Group Inc
$13
Nabriva Therapeutics, plc
$13
Pinnacle Biologics, Inc
$12
Phadia US Inc.
$11
Top 3 companies account for 93.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ALAIR · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CUVITRU · DRIZALMA SPRINKLE · DUPIXENT · Dayvigo · Dymista · ELIQUIS · EXALT Model D · EXPECT · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · GIAPREZA · GLASSIA · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · HyperRAB SD · IMFINZI · ImmunoCAP · Impella · InogenOne · KEYTRUDA · LUMRYZ · Monarch Platform · NUCALA · NUZYRA · Nephrocheck · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Photofrin · Precision Flow · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · REMODULIN · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · VAPOTHERM · Veltassa · Vemlidy · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xembify · Xenleta · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
39
County median income
$68,711
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA POINCIANA HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Umeh is a clinical cardiology specialist, with above-average Medicare volume (top 19% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Umeh experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Umeh performed 730 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Umeh receive payments from pharmaceutical companies?
Yes. Dr. Umeh received a total of $299,782 from 59 companies across 1,153 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Umeh's costs compare to other pulmonary diseases in Kissimmee?
Dr. Umeh's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Umeh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Kissimmee
Browse pulmonary diseases in Kissimmee ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology